Sonneveld MJ, Chiu SM(Co first), Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bommel F, Janssen HL, Berg T, Zoulim F, ....., Chen CH*, Maasoumy B*, CREATE Study Group. Hepatitis B Virus DNA and Hepatitis B e Antigen Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and Hepatitis B Antigen Loss in Hepatitis B e Antigen-Negative Patients Who Discontinued Antiviral Therapy. Gastroenterology. 2024 Jan; 166(1):168-177.e8. (SCI)
Sonneveld MJ, Chiu SM(co-first), Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, Colombatto P, van Bommel F, Berg T, Zoulim F, Hoon Ahn S, Dalekos GN, .......,Chen CH*, Maasoumy B*. CREATE study group Affiliations expnd. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study. JHEP Rep. 2023 Aug ;5(8):100790. (SCI)
Chiu SM, Chang KC, Hu TH, Hung CH, Wang JH, Lu SN, Chen CH*. Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation. Dig Dis Sci. 2023 Feb;68(2):665-675. (SCI)
Sonneveld MJ*, Chiu SM(co-first), Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, van Bommel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Honer Zu Siederdissen C, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH*, Maasoumy B; Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels. CREATE study group. J Hepatol. 2022 May;76(5):1042-1050. (SC
Lai WT#, Chiu SM#, Wu CK, Liang CM, Yang SH, Yao CC, Kuo CM, Lu LS*, Chiu YC, Wu KL, Tai WC, Chuah SK*. Incidence of interval colorectal cancer: A tertiary hospital report. Adv Dig Med. 2021 Sept.; 8(3): 172-177. (台灣消化醫學雜誌)
Chiu SM, Kuo YH, Wang JH, Hung CH, Hu TH, Lu SN, Chen CH*. Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir therapy. Clin Gastroenterol Hepatol. 2020 Dec;18(13):2989-2997.e3. (SCI)
Chiu SM, Tsai MC, Lin CY*, Chen CH, Lu SN, Hung CH, Sheen IS, Chien RN, Lin CL, Hu TH*, Cheng YF, Chen CL. Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment. PLoS One. 2020 Apr 14;15(4):e0231102. (SCI)
